Bone Biologics Corp

Research Bone Biologics Corp (BBLG) on Bullrun: market cap USD 2.48M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBBLG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.48M
• Financial periodFY2025
• Net income-USD 3.11M

Valuation Snapshot

latest market cap is USD 2.48M.

About Bone Biologics Corp

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications.

Frequently asked questions

What is Bone Biologics Corp's market cap?

Bone Biologics Corp's market capitalization is USD 2.48M.

What does Bone Biologics Corp do?

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.